Safety and Efficacy of BRM421 for Dry Eye Syndrome

NCT03066219 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndrome

Interventions

DRUG: BRM421
DRUG: Placebo

Sponsor

BRIM Biotechnology Inc.